The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory

Synapse

Volumn 7, Issue 2, 1991, Pages 151-168

  Decker, Michael W ^a   McGaugh, James L ^b  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acetylcholine; Aging; Alzheimer's disease; Angiotensin II; Dopamine; GABA; Galamin; Learning; Memory; Norepinephrine; Opiates; Serotonin; Substance P

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ANGIOTENSIN; DOPAMINE; GALANIN; NORADRENALIN; SEROTONIN; SUBSTANCE P;

AGING; ALZHEIMER DISEASE; HUMAN; LEARNING; MEMORY; NONHUMAN; REVIEW;

ANIMAL; HUMAN; LEARNING; MEMORY; NEUROTRANSMITTERS; PARASYMPATHETIC NERVOUS SYSTEM; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025851708     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.890070209     Document Type: Review

References (228)

1. Evidence for a possible functinoal interaction between serotonergic and cholinergic mechanisms in memory retrieval
2. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzehimer‐type dementia
3. Active and passive avoidance following the administration of systemic DSP4, xylamine or p‐chloro‐amphetamine
4. Cortical cerebral blood flow is modulated by cholinergic basal forebrain neurons: Effects of ibotenic acid lesions and electrical stimulation
5. α2‐Adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates
6. The alpha‐2 adrenergic agonist gunafacine improves memory in aged monkeys without sedative of hypotensive side effects: Evidence for alpha‐2 receptor subtypes
7. Angiotensin converting enzyme in Alzheimer's disease: Increased activity in caudate nucleus and cortical areas
8. Spontaneous and delayed spatial alternation following damage to specific neuronal elements within the nucleus medianus raphe
9. Biogenic amines and their metabolites in Alzheimer's disease: Noraderenaline, 5‐hydroxytryptamine and 5‐hydroxyindole‐3‐acetic acid depleted in hippocampus but not in substantia innominata
10. Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: A review and some new reuslts
11. Possible interaction between central cholinergic muscarinic and opioid peptidergic systems during memory consolidatin in mice
12. Possible cholinergic‐dopaminergic link in memory facilitaion induced by oxotremorine in mice
13. Angiotensin II inhibits the release of [3H] acetycholine from rat entorhinal cortex in vitro
14. Angiotensin II inhibits acetylcholine release from human temporal cortex: Implication for cognition
15. Short‐term memory in the rhesus monkey: Disruption from the anti‐cholinergic scopolamine
16. The cholinergic hypothesis of geriatric memory dysfunction
17. The cholinergic hypothesisX. A historical overivew, current perspective, and future directions
18. Locomotor hyperactivity in the rat after infusion of muscimol and [D‐Ala2]Metenkephalin into the mucleus basalis magnocellularis
19. Light microscopic evidence for a substance P‐containing innervation of the human nucleus basalis of Meynert
20. Noradrenergic modulation of cortical acetylcholine release is both direct and γ‐aminobutyric acid‐mediated
21. Modulation of visual cortical plasticity by acetylcholine and noradrenaline
22. Scopolamine impairs encoding and retrieval of spatial working memory in rats
23. Spatial working memory in rats: Effects of monoaminergic antagonists
24. The role of dopamine in locomotor activity and learning
25. Drugs for Parkinson's disease; Centrally acting muscle relaxants
26. Muscarinic receptor activation inhibits both release and synthesis of noradrenaline in rat hippocampal synaptosomes
27. Dopamine‐containing systems in the CNS
28. GABA‐A vs. GABA‐B modulation of septal‐hippocampal interconnections
29. Behavioral and neurochemical differentiation of specific projections in the septal‐hippocampal cholinergic pathway of the rat
30. Naloxone‐induced facilitation of latent inhibition in rabbits
31. Effects of opioid microinjections into the medial septal area on spatial memory in rats
32. Post‐training administration of GABAergic antagonists enhances retention of aversively motivated tasks
33. Muscimol injections in the medial septum impair spatial learning
34. Involvement of the amygdala GABAergic system in the modulation of memory storage
35. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey
36. The septo‐hippocampal cholinergic pathway: Role in antagonism of pentobarbital anesthesia and regulation by various afferents
37. Radial maze as a tool for assessing the effect of drugs on the working memory of rats
38. Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze
39. Retrograde memory enhancement by diazepam: Its relation to anterograde amnesia, and some clinical implicatins
40. Post‐training systemic and intra‐amygdala administration of the GABA‐B agonist baclofen impairs retention
41. Central administration of the muscarinic receptor subtype‐selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse
42. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia
43. Intraseptal administration of muscimol produces dose‐dependent memory impairments in the rat
44. Deplectin of brain norepinephrine with DSP‐4 fails to alter acquisition or performance of a radial arm maze task
45. Transplantation of norepinephrine neurons into aged rats improves performance of a learned task
46. Caudate nucleus and memory for egocentric localization
47. Neonatal 6‐hydroxydopa, but not DSP4, elevates brain stem monoamines and impairs inhibitory avoidance learning in developing rats
48. Neonatal DSP4 influences on brain neurochemistry and olfactory learning in developing rats
49. The transsynaptic regulation of the septal‐hippocampal cholinergic neurons
50. Alzheimer's disease: a disorder of cortical cholinergic innervation
51. Co‐existence of galanin and acetylcholine: is galanin involved in memory processes and dementia
52. The effects of antihypertensive therapy on the quality of life
53. Combined administration of physostigmine and clonidine to patients with dementia of the Alzheimer type: A pilot safety study alzheimer Disease Assoc
54. The effects of aging on hippocampal and cortical projection of the forebrain cholinergic system
55. Scopolamine‐disruption of radial arm maze performance: Modification by noradrenergic depletion
56. Effects of concurrent mainpulatin of cholinergic and noradrenergic function on learning and retention in mice
57. Concurrent muscarinic and β‐adrenergic blockade in rats impairs place‐learning in a water maze and retention of inbibitory avoidance
58. Effects of naloxone on Morris water maze learning in the rat: Enhanced acquisition with pretraining but not posttrainig administration
59. Pretraining naloxone enhances Morris water maze performance and alters training‐induced changes in high affinity choline uptake (HACU)
60. Effects of training on a spatial memory task on high affinity choline uptake in hippocampus and cortex in young adult and aged rats
61. A comparison of the effects of scopolamine and diazepam on acquisition and retentin of inhibitory avoidance in mice
62. Memory and cognitive function in man: Does the cholinergic system have a specific role?
63. Behavioural, biochemical and histochemcial effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats
64. The effects of acute intraseptal injection of haloperidol in vivo on hippocampal cholineric function in the mouse
65. Effects of scopolamine, pentobarbital, and amphetamine on radial arm maze performance in rat
66. Acetylcholine acts on M2‐muscarinic receptors to excite rat locus coeruleus neurones
67. An evlauation of the mechanism of scopolamine‐induced impairment in two passive avoidance protocols
68. Effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on visual discrimination acquisition, performance and reversal in the rat
69. Diazepam and memory: Evidence function
70. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: Histochemical, autoradiographic, in vivo, and in vitro studies
71. Behavioral and neurochemical effects following neurotoxic lessions of a major cholinergic input to the cerebral cortex in the rat
72. Loss of cholinergic neurons in the rat neocortex produces deficits in passive avoidance learning
73. Amnesic actions of diazepam and scopolamine in man
74. In vivo modulation of septo‐hippocampal cholinergic activity in mice: relationships with spatial reference and working memory performance
75. Facilitation of spontaneous and learned spatial behaviours following 6‐hydroxydopamine lesions of the lateral septum: A cholinergic hypothesis
76. Re‐viewing modulation of learning and memory
77. Manipulations of opiate activity in the amygdala alters memory processes
78. Spatial learning deficits in old rats: A model for memory decline in the aged
79. Effects of opiate antagonists on spatial memory in young and aged rats
80. Opiate effects in the amygdala central nucleus on heart rate conditioning in rabbits
81. Memory formation: Evidence for a specific neurochemical system in the amygdala
82. Opiate antagonists improve spatial memory
83. Effects of opiate manipulations on latent inhibition in rabbits: Sensitivity of the medial septal region to intracranial treatments
84. Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory
85. Studies on human memory:the interactions of diazepam, scopolamine, and physostigmine
86. Alteration in the action of cholinergic and anti cholinergic drugs after chronic haloperidol: indirect evidence for cholinergic hyposensitivity
87. Changes in learning and memory during aging
88. The mnemon and its juices: Neuromodulation of memory processes
89. The effcts of central catecholamine depletions on spatial learning in rats
90. Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine
91. Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats
92. Faciliated reversal learning of a spatial‐memory task by medial septal injections of 6‐hydroxydopamine
93. Adrenoreceptor antagonist treatment influences revovery of learning following medial septal lesions and hippocampal sympathetic ingrowth
94. Disinhibition in the rat septum mediated by M1 muscarinic receptors
95. Lesios in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments
96. Effects of cholinergic and monoaminergic antagonists and tranquilizers upon spatial memory in rats
97. Effect of cholinergic deficit induced by ethylcholine aziridinium (AF64A) on noradrenergic and dopaminergic parameteres in rat brain
98. The effect of pirenzepine on spatial learning in the morris water maze
99. Brain catecholamines modifcations. The effects on memory facilitation induced by oxotremorine in mice
100. The impairment of retention induced by β‐endorphic in mice may be mediated by a reduction of central cholinergic activity
101. Selective brain noradrenaline depletion induced by the neurotoxin N‐(2‐chloroethyl)‐N‐ethyl‐2‐ bromobenzylamine (DSP 4) does not prevent the memory facilitation induced by a muscarinic agonist in mice
102. Stria terminalis lesions attenuate the effects of posttraining oxotremorine and atropine on retention
103. Effects of nalaxone and morphine on vasrious forms of memory in the rats: Possible role of endogenous opiate mechanisms in memory consolidation
104. Bidirectional effects o f β‐carbolines and benzodiazepines on cognitive processes
105. Benzodiazepines alter acquistition and retention of an inhibitory avoidance response in mice
106. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic catecholamine, serotonin, and acetylcholine neurons
107. Monoaminergic modulation of the sensitivity of neurones in the cingulate cortex to iontophoretically applied substance P
108. Age‐related decrements in the muscarinic enhancement of K+‐evoked release of endogenous striatal dopamine: An indicator of altered cholinergic‐dopaminergic reciprocal inhibitory control in senescene
109. Substance P injected into the region of the nucleus basalis magnocellularis facilitates performance of an inhibitory avoidance task
110. Neurobiological views of memory
111. Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task
112. On the interaction of neurotransmitter systems in processes of learning and memory
113. Age‐related behavioral and neurobiological changes: A review with an emphasis on memory
114. Sodium‐dependent high affinity choline uptake
115. Cortical blood flow response to stimulation of cholinergic neurons of the substantia innominata in young and senescent rats
116. Effects of nicotine on exploratory behavior in rats: Correlation with regional brain monoamine levels
117. Cortical cholinergic impairment and behavioral deficits produced by kainic acid lesions of rat magnocellular basal forebrain
118. Noradrenergic changes and memory loss in aged mice
119. Scopolamine interactions with D1 and D2 antagonists on radial‐arm maze performance in rats
120. Reversal of a mecamylamine‐induced cognitive deficit with the D2 agonist, LY 171555
121. Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial‐arm maze
122. Psychopharmacological effects in the radial‐arm maze
123. Effects of the nicotinic receptor blocker, mecamylamine, on radial‐arm maze performance in rats
124. Modulating effects of posttraining epinephrine on memory: Involvement of the amygdala noradrenergic system
125. Post‐training amygdaloid lesions impair retention of an inhibitory avoidance response
126. The amnesic action of bezodiazepines in man
127. Lesions of cholinergic forebrain nuclei: Changes in avoidance behavior and scopolamine actions
128. Chronic infusion of GABA and saline into the nucleus basalis magnocellularis of rats: II. Cognitive impairments
129. Septal‐noradrenergic antagonism in vivo blocks the testing‐induced activation of septo‐hippocampal cholinergic neurones and produces a concomitant deficit in working memory performance of mice
130. Assessment of retention capacities in old rats
131. Interaction between noradrenergic and cholinergic systems in the rat brain: behavioural function in locomotor activity
132. Possible behavioral function for noradrenaline‐acetylcholine interaction in brain
133. Galanin antagonizes acetylcholine on a memory task in basal forebrain‐lesioned rats
134. Acetylcholine release from rat hippocampal slices is modulated by 5‐hydroxytryptamine
135. Dissociating learning and performance: Drug and hormone enhancement of memory storage
136. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage
137. Neurotransmitter systems in aging and senile dementia
138. Cholinergic‐dopaminergic interactions in radial‐arm maze performance
139. Nicotinic‐dopaminergic relationships and radial‐arm maze performance in rats
140. Radial‐arm maze performance in rats is impaired by a combination of nicotinic‐cholinergic and D2 dopaminergic antagonist drugs
141. Galanin‐like immunoreactivity in hippocampal afferents in the rat with special reference to cholinergic and noradrenergic inputs
142. Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex
143. Intrahiopocampal injections of gallamine impair learning of a memory task
144. Selectivity of pirenzepine in the central nervous system. II. Differential effects of pirenzepine and scopolamine on performance of a representational memory task
145. Nalaxone enhancement of memory
146. Stereoselective blockade at [3H]5‐HT binding sites and at the 5‐HT autoreceptor by propranolol
147. Effects of intraseptally injected dopamine and noradrenaline on hippocampal synchronized theta wave activity in rats
148. Nootropic effects of ACE inhibitors in mice
149. Modulation of cortical acetylcholine and gamma‐aminobutyric acid release in freely moving guinea pigs: Effects of clonidine and other adrenergic drugs
150. Learning and memory deficits after lesions of the nucleus basalis magnocellularis: Reversal by physostigmine
151. Enhanced inhibitory avoidance learning produced by post‐trial injections of substance P into the basal forebrain
152. Combined cholinergic and serotonergic denervation of the forebrain produces severe deficits in a spatial learning task in the rat
153. Neurochemical dissociation of memory systems
154. Scopolamine impairs performance of a place and cue tasks in rats
155. Dementia: Animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system
156. Memory facilitation produced by dopamine agonists: Role of receptor subtype and mnemonic requirements
157. Galanin inhibits the muscarinic stimulation of phosphoinositide turnover in rat ventral hippocampus
158. Neurochemical activities in human temporal lobe related to aging and Alzheimer‐type changes
159. Age‐related cognitive impairments as assessed with an automated repeated measures memory task: implications for the possible role of acetylcholine and norepinephrine in memory dysfunction
160. The significance of animal models for studying the neural basis of age‐related cognitive decline
161. The involvement of the locus coeruleus in memory
162. Is cholinergic activity of the caudate nucleus involved in memory?
163. Scopolamine and benzodiazepine models of dementia: cross reversals by RO 15‐1788 and physostigmine
164. Muscarinic and nicotinic contributions to the AD cortical perfusion abnormality
165. Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin‐type 1 receptors in rat brain
166. High‐affinity choline uptake in hippocampal synaptosomes and learning in the rat
167. Choline uptake and permanent memory storage
168. The effects of intravenous diazepam and hyoscine upon recognition memory
169. Spatial performance is severely impaired in rats with combined reduction of serotonergic and cholinergic transmission
170. Raphe cells grafted into the hippocampus can ameliorate spatial memory deficits in rats with combined sertonergic/cholinergic deficiencies
171. Comparative effects of ibotenic acid‐and quisqualic acid‐induced lesions of the substantia innominata on attentional function in the rat: Further implications for the role of the cholinergic neurons of the nucleus basalis on cognitive processes
172. Effect of Nomifensine and other antidepressant drugs on acetylcholine turnover in various regions of rat brain. N‐S
173. Dopaminergic control of the septal‐hippocampal cholinergic pathway
174. Nicotinic‐cate‐cholaminergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine
175. Scopolamine amnesia of passive avoidance: A deficit of information acquistition
176. Acquisition and retention of different learning tasks in old rats
177. The interaction of acetylcholinergic and serotonergic neural systems on performance in a continuous non‐matching to sample task
178. Attentuation of scopolamine‐induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist β‐carbolines
179. Activating the damaged basal forebrain cholinergic system: Tonic stimulation versus signal amplification
180. Substance P facilitation of memory: Effects in an appetitively motivated learning task
181. Investigation into the age‐dependence of release of serotonin and noradrenaline in the rat brain cortex and of autoreceptor‐mediated modulation of release
182. Potential interactions between GABAb and cholinergic systems: baclofen augments scopolamine‐induced performance deficits in the eight‐arm radial maze
183. Deficits in spatial‐memory tasks following lesions of septal dopaminergic terminals in the rat
184. Autoradiographic distribution of 125I‐galanin binding sites in the rat central nervous system
185. Animal models of Alzheimer's disease: experimental cholinergic denervation
186. Complex maze performance in rats. Effects of noradrenergic depletion and cholinergic blockade
187. Alzheimer's disease: Monoamines and spiperone binding reduced in nucleus basalis
188. Central cholineric involvement in working memory: Effects of scopolamine on continuous nonmatching and discrimination performance in the rat
189. Facilitation of learning by posttrial injection of substance P into the medial septal nucleus
190. Age‐related memory deficits in rats and mice: Enhancement with peripheral injections of epinephrine
191. Scopolamine impairs spatial maze performance in rats
192. Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze
193. Some evidence for amnesic‐like effects of bezodiazepines in animals
194. Differential hippocampal and cortical cholinergic activation during the acquistition, retention, reversal and extinction of a spatial discrimination in an 8‐arm radial maze by mice
195. Near‐total loss of “learning” and “memory” as a result of combined cholinergic and serotonergic blockade in the rat
196. Joint cholinergic‐serotonergic control of neocortical and hippocampal electrical activity in relation to behavior. Effects of scopolamine, ditran, trifluoprazine and amphetamine
197. Modulation of cortical release of acetylcholine by noradrenaline released from nerves arising from the rat locus coeruleus
198. Galanin‐like immunoreactivity within Ch2 neurons in the vertical limb of the diagonal band of Broca in aging and Alzheimer's disease
199. Decreases in behavioral and striatal neuronal responses to dexamphetamine with aging
200. Alpha receptor‐mediated facilitation of somatosensory cortical neuronal responses to excitatory synaptic inputs and iontophoretically applied acetylcholine
201. Differential effects of d‐and l‐propranolol on dopamine turnover stimulated by oxotremorine in striatal and mesolimbic areas of rat brain
202. Behavior alters the uptake of [3H] choline into acetylcholinergic neurons of the nucleus basalis magnocellularis and medial spetal area
203. Neurotransmitters and memory: Role of cholinergic, serotonergic, and noradrenergic systems
204. Pharmacological manipulations of the substantia innominata‐cortical cholinergic pathway
205. Basal forebrain lesions and memory: Alterations in neurotensin, not acetylcholine, may cause amnesia
206. Age‐related changes in multiple neurotransmitter systems in the monkey brain
207. Cholinergic receptor blockade in the rat impairs locale but not taxon strategies for place navigation in a swimming pool
208. Cholinergic receptor blockade produces impairments in sensorimotor subsystem for place navigation in the rat: Evidence from sensory, motor, and acquistition tests in a swimming pool
209. Disruption of central cholinergic systems in the rat by basal forebrain lesion or atropine: Effects on fedding, sensorimotor behaviour, locomotor activity and spatial navigation
210. Specific disruption of spatial behaviour in rats by central muscarinic receptor blockade
211. Differential effects of scopolamine on working and reference memory of rats in the radial maze
212. Catecholamine theories of reward: A critical review
213. Pharmacological evalation of GABAergic and glutamatergic inputs to the nucleus basalis‐cortical and the septal‐hippocampal cholinergic projections
214. GABAergic and opioid regulation of the substantia nigra innominata‐cortical cholinergic pathway in the rat
215. Differential effecfts of M1‐and M2‐muscarinic drugs on striatal dopamine release and metabolism in freely moving rats
216. Dopaminergic denervation reverses behavioral deficits induced by prenatal exposure to phenobarbital
217. Afferent connections of the forebrain cholinergic projection neurons, with special reference to monoaminergic and peptidergic fibers
218. GABAergic input to cholinergic forebrain neurons: An ultrastructural study using retrograde tracing of HRP and double immunolabelin
219. Catecholamine system involvement in agerelated memory dysfunction
220. Rapid forgetting in aged rats
221. Effects of intraseptal drug administration on pentobarbital‐induced narcosis and hippocampal choline uptake